Abstract 2981: Anti-tumor activity of vobramitamab duocarmazine (MGC018), an investigational duocarmycin-based anti-B7-H3 antibody-drug conjugate (ADC), in preclinical neuroblastoma models

Authors: Chiara Brignole, Veronica Bensa, Enzo Calarco, Elena Giusto, Eleonora Ciampi, Patrizia Perri, Maria Valeria Corrias, Simonetta Astigiano, Michele Cilli, Deryk Loo, Ezio Bonvini, Fabio Pastorino, Mirco Ponzoni

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-2981

Source: Full article